These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12226843)

  • 1. Dissolution kinetics of single crystals of alpha-lactose monohydrate.
    Raghavan SL; Ristic RI; Sheen DB; Sherwood JN
    J Pharm Sci; 2002 Oct; 91(10):2166-74. PubMed ID: 12226843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution kinetics of paracetamol single crystals.
    Prasad KV; Ristic RI; Sheen DB; Sherwood JN
    Int J Pharm; 2002 May; 238(1-2):29-41. PubMed ID: 11996808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization and X-ray diffraction of crystals formed in water-plasticized amorphous lactose.
    Jouppila K; Kansikas J; Roos YH
    Biotechnol Prog; 1998; 14(2):347-50. PubMed ID: 9548791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose.
    Haque MK; Roos YH
    Carbohydr Res; 2005 Feb; 340(2):293-301. PubMed ID: 15639249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Templated nucleation of acetaminophen on spherical excipient agglomerates.
    Quon JL; Chadwick K; Wood GP; Sheu I; Brettmann BK; Myerson AS; Trout BL
    Langmuir; 2013 Mar; 29(10):3292-300. PubMed ID: 23414233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative X-ray diffraction determination of alpha-lactose monohydrate and beta-lactose in chocolate.
    Thomas NR; Shumway LS; Hansen LD
    J Food Sci; 2009 Sep; 74(7):C513-8. PubMed ID: 19895454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of theophylline monohydrate and anhydrous theophylline in buffer solutions.
    de Smidt JH; Fokkens JG; Grijseels H; Crommelin DJ
    J Pharm Sci; 1986 May; 75(5):497-501. PubMed ID: 3735090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleation and crystallization kinetics of hydrated amorphous lactose above the glass transition temperature.
    Schmitt EA; Law D; Zhang GG
    J Pharm Sci; 1999 Mar; 88(3):291-6. PubMed ID: 10052985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-resolved near-infrared spectroscopic study of the dissolution of crystalline lactose.
    Hattori Y; Otsuka M
    Eur J Pharm Sci; 2012 Dec; 47(5):884-9. PubMed ID: 23000381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dissolution of cholesterol monohydrate crystals in atherosclerotic plaque lipids.
    North BE; Katz SS; Small DM
    Atherosclerosis; 1978 Jul; 30(3):211-7. PubMed ID: 678318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Mass Transfer within the Crystal-Solution Boundary Layer of l-Alanine {120} Faces Using Laser Interferometry during Growth and Dissolution.
    Nicholson ST; Roberts KJ; Izumi T; Lai X
    Cryst Growth Des; 2023 Apr; 23(4):2755-2769. PubMed ID: 37038400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bulk crystallization of alpha-lactose monohydrate from aqueous solution.
    Raghavan SL; Ristic RI; Sheen DB; Sherwood JN
    J Pharm Sci; 2001 Jul; 90(7):823-32. PubMed ID: 11458332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repair of impurity-poisoned protein crystal surfaces.
    Plomp M; McPherson A; Malkin AJ
    Proteins; 2003 Feb; 50(3):486-95. PubMed ID: 12557190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal modifications and dissolution rate of piroxicam.
    Lyn LY; Sze HW; Rajendran A; Adinarayana G; Dua K; Garg S
    Acta Pharm; 2011 Dec; 61(4):391-402. PubMed ID: 22202198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ab initio structure determination of the hygroscopic anhydrous form of alpha-lactose by powder X-ray diffraction.
    Platteau C; Lefebvre J; Affouard F; Derollez P
    Acta Crystallogr B; 2004 Aug; 60(Pt 4):453-60. PubMed ID: 15258404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D; Young PM; Jones M; Edge S; Price R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization kinetics of amorphous lactose, whey-permeate and whey powders.
    Ibach A; Kind M
    Carbohydr Res; 2007 Jul; 342(10):1357-65. PubMed ID: 17445785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An X-ray diffraction analysis of crystallised whey and whey-permeate powders.
    Nijdam J; Ibach A; Eichhorn K; Kind M
    Carbohydr Res; 2007 Nov; 342(16):2354-64. PubMed ID: 17719020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.